Efficacy of Ozurdex® in the Treatment of Diabetic Macular Edema (DME)
NCT ID: NCT03003416
Last Updated: 2019-03-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
115 participants
OBSERVATIONAL
2017-10-19
2018-12-19
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Retrospective Trial on the Efficacy and Safety of Intravitreal Ozurdex in Patients With Diabetic Macular Edema.
NCT02121197
A Study to Evaluate the Effectiveness and Safety of OZURDEX® in Patients With Diabetic Macular Edema But Never Treated
NCT03953807
Study of Ozurdex® Treatment Practice in Patients With Macular Oedema Due to Retinal Vein Occlusion
NCT01618266
An Observational Study of OZURDEX® in Diabetic Macular Edema (DME)
NCT02188173
Ozurdex for Treatment of Recalcitrant Diabetic Macular Edema
NCT01571232
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
OZURDEX®
Patients prescribed dexamethasone intravitreal implant (OZURDEX®) in clinical practice for the treatment of Diabetic Macular Edema.
dexamethasone intravitreal implant
Dexamethasone intravitreal implant (OZURDEX®) as prescribed in clinical practice.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
dexamethasone intravitreal implant
Dexamethasone intravitreal implant (OZURDEX®) as prescribed in clinical practice.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Allergan
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Nathalie Mesnard
Role: STUDY_DIRECTOR
Allergan
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre MGM
Aix-en-Provence, , France
Ballanger
Aulnay-sous-Bois, , France
CH BLOIS
Blois, , France
CH Avicennes Bobigny
Bobigny, , France
Centre Rétine Gallien à Bordeaux
Bordeaux, , France
CHU Bordeaux
Bordeaux, , France
CHU Brest
Brest, , France
CHI Créteil
Créteil, , France
CH SCORFF - Lorient
Lorient, , France
Hopital De La Croix Rousse
Lyon, , France
Clinique Monticelli
Marseille, , France
Hopital de la Timone
Marseille, , France
CHR Annecy
Metz-Tessy, , France
CHU Pasteur 2
Nice, , France
Chno 1520
Paris, , France
Hopital Saint Joseph
Paris, , France
Fondation Rothschild
Paris, , France
Lariboisiere
Paris, , France
COCHIN
Paris, , France
Hopital Poissy
Poissy, , France
Hôpital de La Milétrie Poitiers
Poitiers, , France
Hopital Saint Germain en Laye
Saint-Germain-en-Laye, , France
Centre OPHTA.Kervision
Saint-Herblain, , France
Maison Rouge
Strasbourg, , France
Chu Toulouse
Toulouse, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Kodjikian L, Delcourt C, Creuzot-Garcher C, Massin P, Conrath J, Velard ME, Lassalle T, Pinchinat S, Dupont-Benjamin L. Prospective, Observational, Multicenter, Real-World Study of the Efficacy, Safety, and Pattern of Use of the Dexamethasone Intravitreal Implant in Diabetic Macular Edema in France: Short-Term Outcomes of LOUVRE 3. Ophthalmol Ther. 2023 Jun;12(3):1671-1692. doi: 10.1007/s40123-023-00662-8. Epub 2023 Mar 26.
Related Links
Access external resources that provide additional context or updates about the study.
More Information
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GMA-EAME-EYE-0440
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.